Today's Top Stories | | By Thomas Hughes | January 27, 2025 09:42 AM |
| | | By The Associated Press | January 28, 2025 05:17 AM |
| | By Nathan Reiff | January 28, 2025 07:45 AM |
| | | By The Associated Press | January 27, 2025 09:50 PM |
| | By Gabriel Osorio-Mazilli | January 28, 2025 07:38 AM |
|
|
Your Watchlist | | | | - Meta Platforms (NASDAQ:META) will be releasing earnings after the market closes on Wednesday, January 29, Financial Modeling Prep reports. (Register for Conference Call)
- CEO Mark Zuckerberg sold 35,921 shares of the firm's stock in a transaction that occurred on Friday, January 24th. The shares were sold at an average price of $644.76, for a total transaction of $23,160,423.96. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
- (1/28) Meta Wins as Judge Denies Class Action Status in Facebook Privacy Lawsuit (tipranks.com)
- (1/28) Insider Selling: Meta Platforms, Inc. (NASDAQ:META) CEO Sells 35,921 Shares of Stock (marketbeat.com)
- (1/28) Fifth Third Bancorp Raises Holdings in Meta Platforms, Inc. (NASDAQ:META) (marketbeat.com)
- (1/28) South Sudan lifts suspension of Facebook and TikTok (reuters.com)
- (1/28) Jefferies Maintains Buy Rating on Meta Platforms, Inc. (META) with $715 Target, Highlights Generative AI Opportunities with META.AI and Llama Models (insidermonkey.com)
| |
| Manage Your Watchlist
|
Analysts' Upgrades | Autodesk (NASDAQ:ADSK) was upgraded by analysts at Mizuho from a "neutral" rating to an "outperform" rating. They now have a $400.00 price target on the stock, up previously from $280.00. This represents a 28.7% upside from the current price of $310.72. | Affirm (NASDAQ:AFRM) was upgraded by analysts at Compass Point from a "sell" rating to a "neutral" rating. They now have a $61.00 price target on the stock, up previously from $20.00. This represents a 9.9% upside from the current price of $55.53. | Astera Labs (NASDAQ:ALAB) was upgraded by analysts at Northland Securities from a "market perform" rating to an "outperform" rating. They now have a $120.00 price target on the stock. This represents a 35.5% upside from the current price of $88.56. | Bancolombia (NYSE:CIB) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $53.00 price target on the stock, up previously from $40.00. This represents a 36.7% upside from the current price of $38.77. | Ciena (NYSE:CIEN) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $88.00 price target on the stock, up previously from $84.00. This represents a 9.4% upside from the current price of $80.41. | CNH GLOBAL N V Foreign (NYSE:CNH) was upgraded by analysts at Oppenheimer Holdings Inc. from a "market perform" rating to an "outperform" rating. They now have a $16.00 price target on the stock. This represents a 20.7% upside from the current price of $13.26. | Cisco Systems (NASDAQ:CSCO) was upgraded by analysts at BNP Paribas from a "neutral" rating to an "outperform" rating. They now have a $72.00 price target on the stock. This represents a 21.6% upside from the current price of $59.23. | Ecolab (NYSE:ECL) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $280.00 price target on the stock, up previously from $263.00. This represents a 12.4% upside from the current price of $249.08. | Roper Technologies (NYSE:ROP) was upgraded by analysts at TD Cowen from a "hold" rating to a "buy" rating. They now have a $615.00 price target on the stock, up previously from $535.00. This represents a 12.5% upside from the current price of $546.45. | Victoria's Secret & Co. (NYSE:VSCO) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $53.00 price target on the stock, up previously from $51.00. This represents a 35.2% upside from the current price of $39.21. | Essential Utilities (NYSE:WTRG) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $41.00 price target on the stock. This represents a 13.8% upside from the current price of $36.02. |
| View More Upgrades
|
Analysts' Downgrades | Advanced Micro Devices (NASDAQ:AMD) was downgraded by analysts at Melius from a "buy" rating to a "hold" rating. They now have a $129.00 price target on the stock, down previously from $160.00. This represents a 12.9% upside from the current price of $114.27. | Eaton (NYSE:ETN) was downgraded by analysts at Melius from a "buy" rating to a "hold" rating. They now have a $373.00 price target on the stock. This represents a 22.7% upside from the current price of $303.88. | Johnson Controls International (NYSE:JCI) was downgraded by analysts at Melius from a "buy" rating to a "hold" rating. They now have a $95.00 price target on the stock. This represents a 24.1% upside from the current price of $76.58. | Logility Supply Chain Solutions (NASDAQ:LGTY) was downgraded by analysts at Maxim Group from a "buy" rating to a "hold" rating.The current price is $14.14. | Trane Technologies (NYSE:TT) was downgraded by analysts at Melius from a "buy" rating to a "hold" rating. They now have a $398.00 price target on the stock. This represents a 8.6% upside from the current price of $366.44. | Vertiv (NYSE:VRT) was downgraded by analysts at Melius from a "buy" rating to a "hold" rating. They now have a $125.00 price target on the stock. This represents a 19.4% upside from the current price of $104.69. |
| View More Downgrades
|
Analysts' New Coverage | Armada Hoffler Properties (NYSE:AHH) is now covered by analysts at Scotiabank. They set a "sector perform" rating and a $11.00 price target on the stock. This represents a 10.6% upside from the current price of $9.95. | Albemarle (NYSE:ALB) is now covered by analysts at Truist Financial Co.. They set a "hold" rating and a $96.00 price target on the stock. This represents a 10.6% upside from the current price of $86.78. | Applied Digital (NASDAQ:APLD) is now covered by analysts at Compass Point. They set a "buy" rating and a $10.00 price target on the stock. This represents a 52.2% upside from the current price of $6.57. | Arcturus Therapeutics (NASDAQ:ARCT) is now covered by analysts at BTIG Research. They set a "buy" rating and a $41.00 price target on the stock. This represents a 143.6% upside from the current price of $16.83. | Chemours (NYSE:CC) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $27.00 price target on the stock. This represents a 41.4% upside from the current price of $19.09. | Cardiol Therapeutics (NASDAQ:CRDL) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $7.00 price target on the stock. This represents a 444.7% upside from the current price of $1.29. | Eledon Pharmaceuticals (NASDAQ:ELDN) is now covered by analysts at Guggenheim. They set a "buy" rating and a $9.00 price target on the stock. This represents a 92.3% upside from the current price of $4.68. | Emerson Electric (NYSE:EMR) is now covered by analysts at Daiwa Capital Markets. They set an "outperform" rating and a $147.00 price target on the stock. This represents a 14.7% upside from the current price of $128.17. | Element Solutions (NYSE:ESI) is now covered by analysts at Truist Financial Co.. They set a "hold" rating and a $28.00 price target on the stock. This represents a 10.0% upside from the current price of $25.44. | Chesapeake Energy (NASDAQ:EXE) is now covered by analysts at Piper Sandler. They set a "neutral" rating and a $96.00 price target on the stock. This represents a 5.5% downside from the current price of $101.61. | Indivior (NASDAQ:INDV) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $16.00 price target on the stock. This represents a 31.9% upside from the current price of $12.13. | INmune Bio (NASDAQ:INMB) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $23.00 price target on the stock. This represents a 191.5% upside from the current price of $7.89. | Mind Medicine (MindMed) (NASDAQ:MNMD) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $23.00 price target on the stock. This represents a 229.3% upside from the current price of $6.98. | Minerals Technologies (NYSE:MTX) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $103.00 price target on the stock. This represents a 32.2% upside from the current price of $77.89. | Oklo (NYSE:OKLO) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $44.00 price target on the stock. This represents a 35.5% upside from the current price of $32.46. | Olin (NYSE:OLN) is now covered by analysts at Truist Financial Co.. They set a "hold" rating and a $38.00 price target on the stock. This represents a 13.7% upside from the current price of $33.41. | PolyPid (NASDAQ:PYPD) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $13.00 price target on the stock. This represents a 322.8% upside from the current price of $3.08. | Tanger (NYSE:SKT) is now covered by analysts at BMO Capital Markets. They set a "market perform" rating and a $36.00 price target on the stock. This represents a 7.0% upside from the current price of $33.65. | Talphera (NASDAQ:TLPH) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $4.00 price target on the stock. This represents a 431.2% upside from the current price of $0.75. | Tronox (NYSE:TROX) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $17.00 price target on the stock. This represents a 65.8% upside from the current price of $10.26. | Vera Therapeutics (NASDAQ:VERA) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $58.00 price target on the stock. This represents a 64.9% upside from the current price of $35.18. | Westlake (NYSE:WLK) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $168.00 price target on the stock. This represents a 40.7% upside from the current price of $119.38. |
| View More New Coverage
|
Calendars from MarketBeat | |
|
Get 30 Days of MarketBeat All Access Free | Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: | Best-in-Class Portfolio MonitoringView the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.Stock Ideas and RecommendationsGet daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.Advanced Stock Screeners and Research ToolsIdentify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
| Start Your 30-Day Free Trial |
| Upgrade Your Subscription | Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET. | Upgrade Now |
|
| Manage Your Watchlist | View and add up to five holdings to your watchlist. | View My Portfolio |
|
| Join Our Facebook Group | Join MarketBeat's free stock discussion and trading idea group on Facebook. | Join Now |
|
|
No comments:
Post a Comment